AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
ProstateProstatic NeoplasmsProstate-Specific AntigenAntineoplastic AgentsCell Line, TumorReceptors, AndrogenAndrogensAndrogen AntagonistsProstatectomyNeoplasmsProstatic HyperplasiaGene Expression Regulation, NeoplasticOrchiectomyNeoplasms, Hormone-DependentDrug Resistance, NeoplasmMice, NudeTumor Markers, BiologicalProstatic Intraepithelial NeoplasiaCell ProliferationAdenocarcinomaApoptosisDisease ProgressionNeoplasm MetastasisEarly Detection of CancerDrug Screening Assays, AntitumorTumor Cells, CulturedTosyl CompoundsMolecular Targeted TherapyBone NeoplasmsXenograft Model Antitumor AssaysNeoplasm ProteinsNeoplasm GradingTransurethral Resection of ProstateDrug DiscoveryNeoplasm StagingNeoplasm InvasivenessAndrogen Receptor AntagonistsSignal TransductionAntineoplastic Agents, HormonalBreast NeoplasmsDigital Rectal ExaminationDihydrotestosteroneDrug DesignReverse Transcriptase Polymerase Chain ReactionGenetic Predisposition to DiseaseAnilidesFinasterideGene Expression ProfilingPrognosisBlotting, WesternWatchful WaitingRisk FactorsCell SurvivalRNA, MessengerNeoplasm TransplantationUnited StatesImmunohistochemistryTransplantation, HeterologousDrug Delivery SystemsCase-Control StudiesClinical Trials as TopicMetriboloneFlutamideCarcinomaDrug ApprovalProstatic DiseasesBiopsyProstatic Neoplasms, Castration-Resistant5-alpha Reductase InhibitorsDrug IndustryCell Growth ProcessesCell CycleBiopsy, NeedleBrachytherapyGlutamate Carboxypeptidase IITime FactorsRiskNeoplasm Recurrence, LocalAnticarcinogenic AgentsProspective StudiesSensitivity and SpecificityFollow-Up StudiesDose-Response Relationship, DrugDown-RegulationRNA, Small InterferingMedical OncologyCell DivisionRisk AssessmentPTEN PhosphohydrolaseTaxoidsMice, SCIDCastrationRetrospective StudiesProstatitisLung NeoplasmsDrug CostsSurvival RateGenotypeTreatment OutcomeSurvival Analysis